Differential radioactive proteomic analysis of microdissected renal cell carcinoma tissue by 54 cm isoelectric focusing in serial immobilized pH gradient gels

Journal of Proteome Research

Volumn 4, Issue 6, 2005, Pages 2117-2125

  Poznanović, Slobodan ^a   Wozny, Wojciech ^a   Schwall, Gerhard P ^a   Sastri, Chaturvedula ^a   Hunzinger, Christian ^a   Stegmann, Werner ^a   Schrattenholz, André ^a   Buchner, Alexander ^b   Gangnus, Rainer ^c   Burgemeister, Renate ^c   Cahill, Michael A ^a  

^a PROTEOSYS AG   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^c PALM Microlaser Technologies AG   (Germany)

Author keywords

Cancer; Immobilized pH gradient; Isoelectric focusing; Laser microdissection; Two dimensional polyacrylamide gel electrophoresis

Indexed keywords

ALDEHYDE DEHYDROGENASE; ALPHA CRYSTALLIN; AMINOACYLASE; CARBONATE DEHYDRATASE I; CARBONYL REDUCTASE; CYCLOPHILIN; ENOLASE; FATTY ACID BINDING PROTEIN; GLUTATHIONE TRANSFERASE; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; HEAT SHOCK PROTEIN 27; IMMUNOGLOBULIN KAPPA CHAIN; IODINE 125; IODINE 131; LECTIN; LIPOCORTIN 4; LIPOCORTIN 5; MANGANESE SUPEROXIDE DISMUTASE; PHOSPHOGLYCERATE KINASE; PHOSPHOGLYCERATE MUTASE; PREALBUMIN; PROTEIN; PYRUVATE KINASE; TRIOSEPHOSPHATE ISOMERASE;

AGED; ARTICLE; CASE REPORT; FEMALE; GERIATRIC PATIENT; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; ISOELECTRIC FOCUSING; ISOTOPE LABELING; KIDNEY CARCINOMA; LASER MICRODISSECTION; NUCLEOTIDE SEQUENCE; PH; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEOMICS; TWO DIMENSIONAL GEL ELECTROPHORESIS;

CARCINOMA, RENAL CELL; CELL LINE, TUMOR; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; ELECTROPHORESIS, POLYACRYLAMIDE GEL; GELS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; HYDROGEN-ION CONCENTRATION; ISOELECTRIC FOCUSING; LASERS; LIVER NEOPLASMS; MASS SPECTROMETRY; ODDS RATIO; PROTEINS; PROTEOME; PROTEOMICS; PROTON-MOTIVE FORCE; RADIOISOTOPES;

EID: 29144449941     PISSN: 15353893     EISSN: None     Source Type: Journal    
DOI: 10.1021/pr050218q     Document Type: Article

References (35)

1. Motzer, R. J.; Bander, N. H.; Nanus, D. M. Renal-cell carcinoma. N. Engl. J. Med. 1996, 335, 865-875.
2. Storkel, S.; Eble, J. N.; Adlakha, K.; Amin, M.; Blute, M. L.; Bostwick, D. G.; Darson, M.; Delahunt, B.; Iczkowski, K. Classification of renal cell carcinoma: Workgroup No. 1. Union Internationale Contre le Cancer (UICC) and the American Joint Committee on Cancer (AJCC). Cancer 1997, 80, 987-989.
3. Ritchie, A. W.; Chisholm, G. D. The natural history of renal carcinoma. Semin. Oncol. 1983, 10, 390-400.
4. Rabinovitch, R. A.; Zelefsky, M. J.; Gaynor, J. J.; Fuks, Z. Patterns of failure following surgical resection of renal cell carcinoma: implications for adjuvant local and systemic therapy. J. Clin. Oncol. 1994, 12, 206-212.
5. Sandock, D. S.; Seftel, A. D.; Resnick, M. I. A new protocol for the followup of renal cell carcinoma based on pathological stage. J. Urol. 1995, 154, 28-31.
6. Yagoda, A.; Abi-Rached, B.; Petrylak, D. Chemotherapy for advanced renal-cell carcinoma: 1983-1993. Semin. Oncol. 1995, 22, 42-60.
7. Atzpodien, J.; Kirchner, H.; Jonas, U.; Bergmann, L.; Schott, H.; Heynemann, H.; Fornara, P.; Loening, S. A.; Roigas, J.; Muller, S. C.; Bodenstein, H.; Pomer, S.; Metzner, B.; Rebmann, U.; Oberneder, R.; Siebels, M.; Wandert, T.; Puchberger, T.; Reitz, M. Interleukin-2- and interferon alfa-2a-based immunochemotherapy in advanced renal cell carcinoma: a Prospectively Randomized Trial of the German Cooperative Renal Carcinoma Chemoimmunotherapy Group (DGCIN). J. Clin. Oncol. 2004, 22, 1188-1194.
8. Schütze, K.; Becker, B.; Bernsen, M.; Bjoernsen, T.; Brocksch, D.; Bush, C.; Clement-Sengewald, A.; van Dijk, M.; Friedemann, G.; Heckl, W.; Lahr, G.; Lindahl, P.; Mayer, A.; Nilsson, S.; Scheidl, S.; Stich, M.; Stolz, W.; Takemoto, M.; Thalhammer, S.; Vogt, T.; Burgemeister, R. Chapter 5: Tissue Microdissection, p 307-356. In DNA Microarrays, A Molecular Cloning Manual; Bowtell, D., Sambrook, J., Eds.; CSHL Press: New York, 2002; Vol. 2.
9. Westphal, G.; Burgemeister, R.; Friedemann, G.; Wellmann, A.; Wernert, N.; Wollscheid, V.; Becker, B.; Vogt, T.; Knuchel, R.; Stolz, W.; Schutze, K. Noncontact laser catapulting: a basic procedure for functional genomics and proteomics. Methods Enzymol. 2002, 356, 80-99.
10. Burgemeister, R.; Schütze, K. "Tissue Microdissection Techniques" In Analysing Gene Expression; Lorkowski, S., Cullen, P., Eds.; Wiley-VCH: Weinheim, Germany, 2003.
11. Burgemeister, R. New aspects of laser microdissection in research and routine. J. Histochem. Cytochem. 2005, 53, 409-412.
12. Schutze, K.; Lahr, G. Identification of expressed genes by laser-mediated manipulation of single cells. Nat. Biotechnol. 1998, 16, 737-742.
13. Scheidl, S. J.; Nilsson, S.; Kalen, M.; Hellstrom, M.; Takemoto, M.; Hakansson, J.; Lindahl, P. mRNA expression profiling of laser microbeam microdissected cells from slender embryonic structures. Am. J. Pathol. 2002, 160, 801-813.
14. Klein, C. A.; Seidl, S.; Petat-Dutter, K.; Offner, S.; Geigl, J. B.; Schmidt-Kittler, O.; Wendler, N.; Passlick, B.; Huber, R. M.; Schlimok, G.; Baeuerle, P. A.; Riethmuller, G. Combined transcriptome and genome analysis of single micrometastatic cells. Nat. Biotechnol. 2002, 20, 387-392.
15. Kondo, T.; Seike, M.; Mori, Y.; Fujii, K.; Yamada, T.; Hirohashi, S. Application of sensitive fluorescent dyes in linkage of laser microdissection and two-dimensional gel electrophoresis as a cancer proteomic study tool. Proteomics 2003, 3, 1758-1766.
16. Sitek, B.; Luttges, J.; Marcus, K.; Kloppel, G.; Schmiegel, W.; Meyer, H. E.; Hahn, S. A.; Stuhler, K. Application of fluorescence difference gel electrophoresis saturation labeling for the analysis of microdissected precursor lesions of pancreatic ductal adenocarcinoma. Proteomics 2005, 27, 27.
17. Patton, W. F. Detection technologies in proteome analysis. J. Chromatogr. B: Analyt. Technol. Biomed. Life Sci. 2002, 771, 3-31.
18. Gruber, H. J.; Hahn, C. D.; Kada, G.; Riener, C. K.; Harms, G. S.; Ahrer, W.; Dax, T. G.; Knaus, H. G. Anomalous fluorescence enhancement of Cy3 and cy3.5 versus anomalous fluorescence loss of Cy5 and Cy7 upon covalent linking to IgG and noncovalent binding to avidin. Bioconjug. Chem. 2000, 11, 696-704.
19. Cahill, M. A.; Wozny, W.; Schwall, G.; Schroer, K.; Holzer, K.; Poznanovic, S.; Hunzinger, C.; Vogt, J. A.; Stegmann, W.; Matthies, H.; Schrattenholz, A. Analysis of relative isotopologue abundances for quantitative profiling of complex protein mixtures labeled with the acrylamide/D3-acrylamide alkylation tag system. Rapid Commun. Mass Spectrom. 2003, 17, 1283-1290.
20. Schrattenholz, A.; Wozny, W.; Klemm, M.; Schroer, K.; Stegmann, W.; Cahill, M. A. Differential and quantitative molecular analysis of ischemia complexity reduction by isotopic labeling of proteins using a neural embryonic stem cell model. J. Neurol. Sci. 2005, 229-230, 261-267.
21. Poland, J.; Cahill, M. A.; Sinha, P. Isoelectric focusing in long immobilized pH gradient gels to improve protein separation in proteomic analysis. Electrophoresis 2003, 24, 1271-1275.
22. Poznanovic, S.; Schwall, G.; Zengerling, H.; Cahill, M. A. Isoelectric focusing in serial immobilized pH gradient gels to improve protein separation in proteomic analysis. Electrophoresis 2005, 26, 3185-3190.
23. Sobin, L., Wittekind, C. Eds. TNM Classification of Malignant Tumours, 6th ed.; John Wiley & Sons: New York, 2002.
24. Melle, C.; Ernst, G.; Schimmel, B.; Bleul, A.; Koscielny, S.; Wiesner, A.; Bogumil, R.; Moller, U.; Osterloh, D.; Halbhuber, K. J.; von Eggeling, F. A technical triade for proteomic identification and characterization of cancer biomarkers. Cancer Res. 2004, 64, 4099-4104.
25. Roesch, A.; Vogt, T.; Stolz, W.; Dugas, M.; Landthaler, M.; Becker, B. Discrimination between gene expression patterns in the invasive margin and the tumour core of malignant melanomas. Melanoma Res. 2003, 13, 503-509.
26. von Eggeling, F.; Melle, C.; Ernst, G. Biomarker discovery by tissue microdissection and ProteinChip array analysis. J. Lab. Med. 2003, 27, 79-84.
27. Tannapfel, A.; Anhalt, K.; Hausermann, P.; Sommerer, F.; Benicke, M.; Uhlmann, D.; Witzigmann, H.; Hauss, J.; Wittekind, C. Identification of novel proteins associated with hepatocellular carcinomas using protein microarrays. J. Pathol. 2003, 201, 238-249.
28. Vuong, G. L.; Weiss, S. M.; Kammer, W.; Priemer, M.; Vingron, M.; Nordheim, A.; Cahill, M. A. Improved sensitivity proteomics by postharvest alkylation and radioactive labeling of proteins. Electrophoresis 2000, 21, 2594-2605.
29. Vogt, J. A.; Schroer, K.; Holzer, K.; Hunzinger, C.; Klemm, M.; Biefang-Arndt, K.; Schillo, S.; Cahill, M. A.; Schrattenholz, A.; Matthies, H.; Stegmann, W. Protein abundance quantification in embryonic stem cells using incomplete metabolic labeling with 15N amino acids, matrix-assisted laser desorption/ionisation time-of-flight mass spectrometry, and analysis of relative isotopologue abundances of peptides. Rapid Commun. Mass Spectrom. 2003, 17, 1273-1282.
30. Gorg, A.; Weiss, W.; Dunn, M. J. Current two-dimensional electrophoresis technology for proteomics (vol. 4, Issue 12, pp 3665-3685). Proteomics 2004, 4, 3665-3685.
31. Righetti, P. G. Bioanalysis: its past, present, and some future. Electrophoresis 2004, 25, 2111-2127.
32. Righetti, P. G.; Castagna, A.; Antonioli, P.; Boschetti, E. Prefractionation techniques in proteome analysis: the mining tools of the third millennium. Electrophoresis 2005, 26, 297-319.
33. Herbert, B.; Righetti, P. G. A turning point in proteome analysis: sample prefractionation via multicompartment electrolyzers with isoelectric membranes. Electrophoresis 2000, 21, 3639-3648.
34. Nass, S. J.; Davidson, N. E. The biology of breast cancer. Hematol. Oncol. Clin. North Am. 1999, 13, 311-332.
35. Smitherman, A. B.; Mohler, J. L.; Maygarden, S. J.; Ornstein, D. K. Expression of annexin I, II and VII proteins in androgen stimulated and recurrent prostate cancer. J. Urol. 2004, 171, 916-920.